Glioma	0	6	B-Cell
tumor	7	12	I-Cell
stem	13	17	I-Cell
-	17	18	I-Cell
like	18	22	I-Cell
cells	23	28	I-Cell
promote	29	36	O
tumor	37	42	B-Pathological_formation
angiogenesis	43	55	O
and	56	59	O
vasculogenesis	60	74	O
via	75	78	O
vascular	79	87	B-Gene_or_gene_product
endothelial	88	99	I-Gene_or_gene_product
growth	100	106	I-Gene_or_gene_product
factor	107	113	I-Gene_or_gene_product
and	114	117	O
stromal	118	125	B-Gene_or_gene_product
-	125	126	I-Gene_or_gene_product
derived	126	133	I-Gene_or_gene_product
factor	134	140	I-Gene_or_gene_product
1	141	142	I-Gene_or_gene_product
.	142	143	O

Cancer	145	151	B-Cell
stem	152	156	I-Cell
cells	157	162	I-Cell
(	163	164	O
CSC	164	167	B-Cell
)	167	168	O
are	169	172	O
predicted	173	182	O
to	183	185	O
be	186	188	O
critical	189	197	O
drivers	198	205	O
of	206	208	O
tumor	209	214	B-Pathological_formation
progression	215	226	O
due	227	230	O
to	231	233	O
their	234	239	O
self	240	244	O
-	244	245	O
renewal	245	252	O
capacity	253	261	O
and	262	265	O
limitless	266	275	O
proliferative	276	289	O
potential	290	299	O
.	299	300	O

An	301	303	O
emerging	304	312	O
area	313	317	O
of	318	320	O
research	321	329	O
suggests	330	338	O
that	339	343	O
CSC	344	347	B-Cell
may	348	351	O
also	352	356	O
support	357	364	O
tumor	365	370	B-Pathological_formation
progression	371	382	O
by	383	385	O
promoting	386	395	O
tumor	396	401	B-Pathological_formation
angiogenesis	402	414	O
.	414	415	O

To	416	418	O
investigate	419	430	O
how	431	434	O
CSC	435	438	B-Cell
contribute	439	449	O
to	450	452	O
tumor	453	458	B-Pathological_formation
vascular	459	467	B-Multi-tissue_structure
development	468	479	O
,	479	480	O
we	481	483	O
used	484	488	O
an	489	491	O
approach	492	500	O
comparing	501	510	O
tumor	511	516	B-Pathological_formation
xenografts	517	527	O
of	528	530	O
the	531	534	O
C6	535	537	B-Cell
glioma	538	544	I-Cell
cell	545	549	I-Cell
line	550	554	I-Cell
containing	555	565	O
either	566	572	O
a	573	574	O
low	575	578	O
or	579	581	O
a	582	583	O
high	584	588	O
fraction	589	597	O
of	598	600	O
CSC	601	604	B-Cell
.	604	605	O

Compared	606	614	O
with	615	619	O
CSC	620	623	B-Pathological_formation
-	623	624	I-Pathological_formation
low	624	627	I-Pathological_formation
tumors	628	634	I-Pathological_formation
,	634	635	O
CSC	636	639	B-Pathological_formation
-	639	640	I-Pathological_formation
high	640	644	I-Pathological_formation
tumors	645	651	I-Pathological_formation
exhibited	652	661	O
increased	662	671	O
microvessel	672	683	B-Tissue
density	684	691	O
and	692	695	O
blood	696	701	B-Organism_substance
perfusion	702	711	O
and	712	715	O
induced	716	723	O
increased	724	733	O
mobilization	734	746	O
and	747	750	O
tumor	751	756	B-Pathological_formation
recruitment	757	768	O
of	769	771	O
bone	772	776	B-Multi-tissue_structure
marrow	777	783	I-Multi-tissue_structure
-	783	784	O
derived	784	791	O
endothelial	792	803	B-Cell
progenitor	804	814	I-Cell
cells	815	820	I-Cell
(	821	822	O
EPC	822	825	B-Cell
)	825	826	O
.	826	827	O

CSC	828	831	B-Cell
-	831	832	I-Cell
high	832	836	I-Cell
C6	837	839	I-Cell
cell	840	844	I-Cell
cultures	845	853	I-Cell
also	854	858	O
induced	859	866	O
higher	867	873	O
levels	874	880	O
of	881	883	O
endothelial	884	895	B-Cell
cell	896	900	I-Cell
proliferation	901	914	O
and	915	918	O
tubule	919	925	B-Tissue
organization	926	938	O
in	939	941	O
vitro	942	947	O
compared	948	956	O
with	957	961	O
CSC	962	965	B-Cell
-	965	966	I-Cell
low	966	969	I-Cell
cultures	970	978	I-Cell
.	978	979	O

CSC	980	983	B-Cell
-	983	984	I-Cell
high	984	988	I-Cell
cultures	989	997	I-Cell
and	998	1001	O
tumors	1002	1008	B-Pathological_formation
expressed	1009	1018	O
increased	1019	1028	O
levels	1029	1035	O
of	1036	1038	O
the	1039	1042	O
proangiogenic	1043	1056	O
factors	1057	1064	O
vascular	1065	1073	B-Gene_or_gene_product
endothelial	1074	1085	I-Gene_or_gene_product
growth	1086	1092	I-Gene_or_gene_product
factor	1093	1099	I-Gene_or_gene_product
and	1100	1103	O
stromal	1104	1111	B-Gene_or_gene_product
-	1111	1112	I-Gene_or_gene_product
derived	1112	1119	I-Gene_or_gene_product
factor	1120	1126	I-Gene_or_gene_product
1	1127	1128	I-Gene_or_gene_product
,	1128	1129	O
and	1130	1133	O
when	1134	1138	O
signaling	1139	1148	O
by	1149	1151	O
either	1152	1158	O
factor	1159	1165	O
was	1166	1169	O
blocked	1170	1177	O
,	1177	1178	O
all	1179	1182	O
aspects	1183	1190	O
of	1191	1193	O
angiogenesis	1194	1206	O
observed	1207	1215	O
in	1216	1218	O
CSC	1219	1222	B-Cell
-	1222	1223	I-Cell
high	1223	1227	I-Cell
cultures	1228	1236	I-Cell
and	1237	1240	O
tumors	1241	1247	B-Pathological_formation
,	1247	1248	O
including	1249	1258	O
microvessel	1259	1270	B-Tissue
density	1271	1278	O
,	1278	1279	O
perfusion	1280	1289	O
,	1289	1290	O
EPC	1291	1294	B-Cell
mobilization	1295	1307	O
/	1307	1308	O
recruitment	1308	1319	O
,	1319	1320	O
and	1321	1324	O
stimulation	1325	1336	O
of	1337	1339	O
endothelial	1340	1351	B-Cell
cell	1352	1356	I-Cell
activity	1357	1365	O
,	1365	1366	O
were	1367	1371	O
reduced	1372	1379	O
to	1380	1382	O
levels	1383	1389	O
comparable	1390	1400	O
with	1401	1405	O
those	1406	1411	O
observed	1412	1420	O
in	1421	1423	O
CSC	1424	1427	B-Cell
-	1427	1428	I-Cell
low	1428	1431	I-Cell
cultures	1432	1440	I-Cell
/	1440	1441	O
tumors	1441	1447	B-Pathological_formation
.	1447	1448	O

These	1449	1454	O
results	1455	1462	O
suggest	1463	1470	O
that	1471	1475	O
CSC	1476	1479	B-Cell
contribute	1480	1490	O
to	1491	1493	O
tumor	1494	1499	B-Pathological_formation
angiogenesis	1500	1512	O
by	1513	1515	O
promoting	1516	1525	O
both	1526	1530	O
local	1531	1536	O
endothelial	1537	1548	B-Cell
cell	1549	1553	I-Cell
activity	1554	1562	O
and	1563	1566	O
systemic	1567	1575	O
angiogenic	1576	1586	O
processes	1587	1596	O
involving	1597	1606	O
bone	1607	1611	B-Multi-tissue_structure
marrow	1612	1618	I-Multi-tissue_structure
-	1618	1619	O
derived	1619	1626	O
EPC	1627	1630	B-Cell
in	1631	1633	O
a	1634	1635	O
vascular	1636	1644	B-Gene_or_gene_product
endothelial	1645	1656	I-Gene_or_gene_product
growth	1657	1663	I-Gene_or_gene_product
factor	1664	1670	I-Gene_or_gene_product
-	1670	1671	O
dependent	1671	1680	O
and	1681	1684	O
stromal	1685	1692	B-Gene_or_gene_product
-	1692	1693	I-Gene_or_gene_product
derived	1693	1700	I-Gene_or_gene_product
factor	1701	1707	I-Gene_or_gene_product
1	1708	1709	I-Gene_or_gene_product
-	1709	1710	O
dependent	1710	1719	O
manner	1720	1726	O
.	1726	1727	O

